Table of Content

1 Anti-Viral Cold And Flu Granule Market Overview
1.1 Product Overview and Scope of Anti-Viral Cold And Flu Granule
1.2 Anti-Viral Cold And Flu Granule Segment by Type
1.2.1 Global Anti-Viral Cold And Flu Granule Market Value Comparison by Type (2024-2034)
1.2.2 Children's Edition
1.2.3 Adults' Edition
1.3 Anti-Viral Cold And Flu Granule Segment by Application
1.3.1 Global Anti-Viral Cold And Flu Granule Market Value by Application: (2024-2034)
1.3.2 Retail Pharmacies
1.3.3 Hospital
1.3.4 Online Sales Platforms
1.4 Global Anti-Viral Cold And Flu Granule Market Size Estimates and Forecasts
1.4.1 Global Anti-Viral Cold And Flu Granule Revenue 2024-2034
1.4.2 Global Anti-Viral Cold And Flu Granule Sales 2024-2034
1.4.3 Global Anti-Viral Cold And Flu Granule Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Anti-Viral Cold And Flu Granule Market Competition by Manufacturers
2.1 Global Anti-Viral Cold And Flu Granule Sales Market Share by Manufacturers (2024-2024)
2.2 Global Anti-Viral Cold And Flu Granule Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Anti-Viral Cold And Flu Granule Average Price by Manufacturers (2024-2024)
2.4 Global Anti-Viral Cold And Flu Granule Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Product Type & Application
2.7 Anti-Viral Cold And Flu Granule Market Competitive Situation and Trends
2.7.1 Anti-Viral Cold And Flu Granule Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Viral Cold And Flu Granule Players Market Share by Revenue
2.7.3 Global Anti-Viral Cold And Flu Granule Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Viral Cold And Flu Granule Retrospective Market Scenario by Region
3.1 Global Anti-Viral Cold And Flu Granule Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Anti-Viral Cold And Flu Granule Global Anti-Viral Cold And Flu Granule Sales by Region: 2024-2034
3.2.1 Global Anti-Viral Cold And Flu Granule Sales by Region: 2024-2024
3.2.2 Global Anti-Viral Cold And Flu Granule Sales by Region: 2024-2034
3.3 Global Anti-Viral Cold And Flu Granule Global Anti-Viral Cold And Flu Granule Revenue by Region: 2024-2034
3.3.1 Global Anti-Viral Cold And Flu Granule Revenue by Region: 2024-2024
3.3.2 Global Anti-Viral Cold And Flu Granule Revenue by Region: 2024-2034
3.4 North America Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.4.1 North America Anti-Viral Cold And Flu Granule Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Anti-Viral Cold And Flu Granule Sales by Country (2024-2034)
3.4.3 North America Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.5.1 Europe Anti-Viral Cold And Flu Granule Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Anti-Viral Cold And Flu Granule Sales by Country (2024-2034)
3.5.3 Europe Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Viral Cold And Flu Granule Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Anti-Viral Cold And Flu Granule Sales by Country (2024-2034)
3.6.3 Asia Pacific Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.7.1 Latin America Anti-Viral Cold And Flu Granule Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Anti-Viral Cold And Flu Granule Sales by Country (2024-2034)
3.7.3 Latin America Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-Viral Cold And Flu Granule Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Viral Cold And Flu Granule Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Country (2024-2034)
3.8.3 Middle East and Africa Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2034)
4.1.1 Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2024)
4.1.2 Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2034)
4.1.3 Global Anti-Viral Cold And Flu Granule Sales Market Share by Type (2024-2034)
4.2 Global Anti-Viral Cold And Flu Granule Revenue by Type (2024-2034)
4.2.1 Global Anti-Viral Cold And Flu Granule Revenue by Type (2024-2024)
4.2.2 Global Anti-Viral Cold And Flu Granule Revenue by Type (2024-2034)
4.2.3 Global Anti-Viral Cold And Flu Granule Revenue Market Share by Type (2024-2034)
4.3 Global Anti-Viral Cold And Flu Granule Price by Type (2024-2034)
5 Segment by Application
5.1 Global Anti-Viral Cold And Flu Granule Sales by Application (2024-2034)
5.1.1 Global Anti-Viral Cold And Flu Granule Sales by Application (2024-2024)
5.1.2 Global Anti-Viral Cold And Flu Granule Sales by Application (2024-2034)
5.1.3 Global Anti-Viral Cold And Flu Granule Sales Market Share by Application (2024-2034)
5.2 Global Anti-Viral Cold And Flu Granule Revenue by Application (2024-2034)
5.2.1 Global Anti-Viral Cold And Flu Granule Revenue by Application (2024-2024)
5.2.2 Global Anti-Viral Cold And Flu Granule Revenue by Application (2024-2034)
5.2.3 Global Anti-Viral Cold And Flu Granule Revenue Market Share by Application (2024-2034)
5.3 Global Anti-Viral Cold And Flu Granule Price by Application (2024-2034)
6 Key Companies Profiled
6.1 WELEDA
6.1.1 WELEDA Corporation Information
6.1.2 WELEDA Description and Business Overview
6.1.3 WELEDA Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.1.4 WELEDA Anti-Viral Cold And Flu Granule Product Portfolio
6.1.5 WELEDA Recent Developments/Updates
6.2 Sichuan Everbright Pharmaceutical
6.2.1 Sichuan Everbright Pharmaceutical Corporation Information
6.2.2 Sichuan Everbright Pharmaceutical Description and Business Overview
6.2.3 Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.2.5 Sichuan Everbright Pharmaceutical Recent Developments/Updates
6.3 Shandong Wohua Pharmaceutical
6.3.1 Shandong Wohua Pharmaceutical Corporation Information
6.3.2 Shandong Wohua Pharmaceutical Description and Business Overview
6.3.3 Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.3.5 Shandong Wohua Pharmaceutical Recent Developments/Updates
6.4 Liaoning Xingao Pharmaceutical
6.4.1 Liaoning Xingao Pharmaceutical Corporation Information
6.4.2 Liaoning Xingao Pharmaceutical Description and Business Overview
6.4.3 Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.4.5 Liaoning Xingao Pharmaceutical Recent Developments/Updates
6.5 Hubei Longda Medicine Technology
6.5.1 Hubei Longda Medicine Technology Corporation Information
6.5.2 Hubei Longda Medicine Technology Description and Business Overview
6.5.3 Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Product Portfolio
6.5.5 Hubei Longda Medicine Technology Recent Developments/Updates
6.6 Guangzhou Huacheng pharmaceutical plant
6.6.1 Guangzhou Huacheng pharmaceutical plant Corporation Information
6.6.2 Guangzhou Huacheng pharmaceutical plant Description and Business Overview
6.6.3 Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Product Portfolio
6.6.5 Guangzhou Huacheng pharmaceutical plant Recent Developments/Updates
6.7 Confidence
6.6.1 Confidence Corporation Information
6.6.2 Confidence Description and Business Overview
6.6.3 Confidence Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Confidence Anti-Viral Cold And Flu Granule Product Portfolio
6.7.5 Confidence Recent Developments/Updates
6.8 Zhuhai AIA Pharmaceutical
6.8.1 Zhuhai AIA Pharmaceutical Corporation Information
6.8.2 Zhuhai AIA Pharmaceutical Description and Business Overview
6.8.3 Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.8.5 Zhuhai AIA Pharmaceutical Recent Developments/Updates
6.9 Taihua Pharmacy
6.9.1 Taihua Pharmacy Corporation Information
6.9.2 Taihua Pharmacy Description and Business Overview
6.9.3 Taihua Pharmacy Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Taihua Pharmacy Anti-Viral Cold And Flu Granule Product Portfolio
6.9.5 Taihua Pharmacy Recent Developments/Updates
6.10 Jiangsu Jurong Pharmaceutical
6.10.1 Jiangsu Jurong Pharmaceutical Corporation Information
6.10.2 Jiangsu Jurong Pharmaceutical Description and Business Overview
6.10.3 Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.10.5 Jiangsu Jurong Pharmaceutical Recent Developments/Updates
6.11 Jiangsu Kanion Pharmaceutical
6.11.1 Jiangsu Kanion Pharmaceutical Corporation Information
6.11.2 Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.11.3 Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.11.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
6.12 Laotongjun Pharmaceutical
6.12.1 Laotongjun Pharmaceutical Corporation Information
6.12.2 Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.12.3 Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.12.5 Laotongjun Pharmaceutical Recent Developments/Updates
6.13 Wuhan Jinpu Pharmaceutical
6.13.1 Wuhan Jinpu Pharmaceutical Corporation Information
6.13.2 Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.13.3 Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.13.5 Wuhan Jinpu Pharmaceutical Recent Developments/Updates
6.14 Jiangsu Xinxian Pharmaceutical
6.14.1 Jiangsu Xinxian Pharmaceutical Corporation Information
6.14.2 Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.14.3 Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.14.5 Jiangsu Xinxian Pharmaceutical Recent Developments/Updates
6.15 Quetzal
6.15.1 Quetzal Corporation Information
6.15.2 Quetzal Anti-Viral Cold And Flu Granule Description and Business Overview
6.15.3 Quetzal Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Quetzal Anti-Viral Cold And Flu Granule Product Portfolio
6.15.5 Quetzal Recent Developments/Updates
6.16 Kangxin Pharmaceutical
6.16.1 Kangxin Pharmaceutical Corporation Information
6.16.2 Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.16.3 Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.16.5 Kangxin Pharmaceutical Recent Developments/Updates
6.17 SHANXI TAIHANG PHARMACEUTICAL
6.17.1 SHANXI TAIHANG PHARMACEUTICAL Corporation Information
6.17.2 SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Description and Business Overview
6.17.3 SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.17.4 SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Product Portfolio
6.17.5 SHANXI TAIHANG PHARMACEUTICAL Recent Developments/Updates
6.18 Henan Tongyuan Pharmaceutical
6.18.1 Henan Tongyuan Pharmaceutical Corporation Information
6.18.2 Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.18.3 Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.18.5 Henan Tongyuan Pharmaceutical Recent Developments/Updates
6.19 BAIHUI PHARMA
6.19.1 BAIHUI PHARMA Corporation Information
6.19.2 BAIHUI PHARMA Anti-Viral Cold And Flu Granule Description and Business Overview
6.19.3 BAIHUI PHARMA Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.19.4 BAIHUI PHARMA Anti-Viral Cold And Flu Granule Product Portfolio
6.19.5 BAIHUI PHARMA Recent Developments/Updates
6.20 Xiangxue Pharmaceutical
6.20.1 Xiangxue Pharmaceutical Corporation Information
6.20.2 Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Description and Business Overview
6.20.3 Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Product Portfolio
6.20.5 Xiangxue Pharmaceutical Recent Developments/Updates
6.21 North Hulunbuir pharmaceutical limited company
6.21.1 North Hulunbuir pharmaceutical limited company Corporation Information
6.21.2 North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Description and Business Overview
6.21.3 North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
6.21.4 North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Product Portfolio
6.21.5 North Hulunbuir pharmaceutical limited company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Viral Cold And Flu Granule Industry Chain Analysis
7.2 Anti-Viral Cold And Flu Granule Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Viral Cold And Flu Granule Production Mode & Process
7.4 Anti-Viral Cold And Flu Granule Sales and Marketing
7.4.1 Anti-Viral Cold And Flu Granule Sales Channels
7.4.2 Anti-Viral Cold And Flu Granule Distributors
7.5 Anti-Viral Cold And Flu Granule Customers
8 Anti-Viral Cold And Flu Granule Market Dynamics
8.1 Anti-Viral Cold And Flu Granule Industry Trends
8.2 Anti-Viral Cold And Flu Granule Market Drivers
8.3 Anti-Viral Cold And Flu Granule Market Challenges
8.4 Anti-Viral Cold And Flu Granule Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Viral Cold And Flu Granule Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Anti-Viral Cold And Flu Granule Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Anti-Viral Cold And Flu Granule Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti-Viral Cold And Flu Granule Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Anti-Viral Cold And Flu Granule Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Anti-Viral Cold And Flu Granule Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Anti-Viral Cold And Flu Granule Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Anti-Viral Cold And Flu Granule, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Viral Cold And Flu Granule, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Viral Cold And Flu Granule by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Viral Cold And Flu Granule as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Viral Cold And Flu Granule Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Anti-Viral Cold And Flu Granule Sales by Region (2024-2024) & (K Units)
Table 18. Global Anti-Viral Cold And Flu Granule Sales Market Share by Region (2024-2024)
Table 19. Global Anti-Viral Cold And Flu Granule Sales by Region (2024-2034) & (K Units)
Table 20. Global Anti-Viral Cold And Flu Granule Sales Market Share by Region (2024-2034)
Table 21. Global Anti-Viral Cold And Flu Granule Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Region (2024-2024)
Table 23. Global Anti-Viral Cold And Flu Granule Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Region (2024-2034)
Table 25. North America Anti-Viral Cold And Flu Granule Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (K Units)
Table 27. North America Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (K Units)
Table 28. North America Anti-Viral Cold And Flu Granule Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Anti-Viral Cold And Flu Granule Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (K Units)
Table 32. Europe Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (K Units)
Table 33. Europe Anti-Viral Cold And Flu Granule Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Anti-Viral Cold And Flu Granule Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Anti-Viral Cold And Flu Granule Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Anti-Viral Cold And Flu Granule Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Anti-Viral Cold And Flu Granule Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Viral Cold And Flu Granule Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Anti-Viral Cold And Flu Granule Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Anti-Viral Cold And Flu Granule Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Anti-Viral Cold And Flu Granule Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Anti-Viral Cold And Flu Granule Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-Viral Cold And Flu Granule Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Anti-Viral Cold And Flu Granule Sales (K Units) by Type (2024-2024)
Table 51. Global Anti-Viral Cold And Flu Granule Sales (K Units) by Type (2024-2034)
Table 52. Global Anti-Viral Cold And Flu Granule Sales Market Share by Type (2024-2024)
Table 53. Global Anti-Viral Cold And Flu Granule Sales Market Share by Type (2024-2034)
Table 54. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Type (2024-2024)
Table 57. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Type (2024-2034)
Table 58. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Type (2024-2024)
Table 59. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Type (2024-2034)
Table 60. Global Anti-Viral Cold And Flu Granule Sales (K Units) by Application (2024-2024)
Table 61. Global Anti-Viral Cold And Flu Granule Sales (K Units) by Application (2024-2034)
Table 62. Global Anti-Viral Cold And Flu Granule Sales Market Share by Application (2024-2024)
Table 63. Global Anti-Viral Cold And Flu Granule Sales Market Share by Application (2024-2034)
Table 64. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Anti-Viral Cold And Flu Granule Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Application (2024-2024)
Table 67. Global Anti-Viral Cold And Flu Granule Revenue Market Share by Application (2024-2034)
Table 68. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Application (2024-2024)
Table 69. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Application (2024-2034)
Table 70. WELEDA Corporation Information
Table 71. WELEDA Description and Business Overview
Table 72. WELEDA Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. WELEDA Anti-Viral Cold And Flu Granule Product
Table 74. WELEDA Recent Developments/Updates
Table 75. Sichuan Everbright Pharmaceutical Corporation Information
Table 76. Sichuan Everbright Pharmaceutical Description and Business Overview
Table 77. Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 79. Sichuan Everbright Pharmaceutical Recent Developments/Updates
Table 80. Shandong Wohua Pharmaceutical Corporation Information
Table 81. Shandong Wohua Pharmaceutical Description and Business Overview
Table 82. Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 84. Shandong Wohua Pharmaceutical Recent Developments/Updates
Table 85. Liaoning Xingao Pharmaceutical Corporation Information
Table 86. Liaoning Xingao Pharmaceutical Description and Business Overview
Table 87. Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 89. Liaoning Xingao Pharmaceutical Recent Developments/Updates
Table 90. Hubei Longda Medicine Technology Corporation Information
Table 91. Hubei Longda Medicine Technology Description and Business Overview
Table 92. Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Product
Table 94. Hubei Longda Medicine Technology Recent Developments/Updates
Table 95. Guangzhou Huacheng pharmaceutical plant Corporation Information
Table 96. Guangzhou Huacheng pharmaceutical plant Description and Business Overview
Table 97. Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Product
Table 99. Guangzhou Huacheng pharmaceutical plant Recent Developments/Updates
Table 100. Confidence Corporation Information
Table 101. Confidence Description and Business Overview
Table 102. Confidence Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Confidence Anti-Viral Cold And Flu Granule Product
Table 104. Confidence Recent Developments/Updates
Table 105. Zhuhai AIA Pharmaceutical Corporation Information
Table 106. Zhuhai AIA Pharmaceutical Description and Business Overview
Table 107. Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 109. Zhuhai AIA Pharmaceutical Recent Developments/Updates
Table 110. Taihua Pharmacy Corporation Information
Table 111. Taihua Pharmacy Description and Business Overview
Table 112. Taihua Pharmacy Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Taihua Pharmacy Anti-Viral Cold And Flu Granule Product
Table 114. Taihua Pharmacy Recent Developments/Updates
Table 115. Jiangsu Jurong Pharmaceutical Corporation Information
Table 116. Jiangsu Jurong Pharmaceutical Description and Business Overview
Table 117. Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 119. Jiangsu Jurong Pharmaceutical Recent Developments/Updates
Table 120. Jiangsu Kanion Pharmaceutical Corporation Information
Table 121. Jiangsu Kanion Pharmaceutical Description and Business Overview
Table 122. Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 124. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
Table 125. Laotongjun Pharmaceutical Corporation Information
Table 126. Laotongjun Pharmaceutical Description and Business Overview
Table 127. Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 129. Laotongjun Pharmaceutical Recent Developments/Updates
Table 130. Wuhan Jinpu Pharmaceutical Corporation Information
Table 131. Wuhan Jinpu Pharmaceutical Description and Business Overview
Table 132. Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 134. Wuhan Jinpu Pharmaceutical Recent Developments/Updates
Table 135. Jiangsu Xinxian Pharmaceutical Corporation Information
Table 136. Jiangsu Xinxian Pharmaceutical Description and Business Overview
Table 137. Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 139. Jiangsu Xinxian Pharmaceutical Recent Developments/Updates
Table 140. Quetzal Corporation Information
Table 141. Quetzal Description and Business Overview
Table 142. Quetzal Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Quetzal Anti-Viral Cold And Flu Granule Product
Table 144. Quetzal Recent Developments/Updates
Table 145. Kangxin Pharmaceutical Corporation Information
Table 146. Kangxin Pharmaceutical Description and Business Overview
Table 147. Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 149. Kangxin Pharmaceutical Recent Developments/Updates
Table 150. SHANXI TAIHANG PHARMACEUTICAL Corporation Information
Table 151. SHANXI TAIHANG PHARMACEUTICAL Description and Business Overview
Table 152. SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Product
Table 154. SHANXI TAIHANG PHARMACEUTICAL Recent Developments/Updates
Table 155. Henan Tongyuan Pharmaceutical Corporation Information
Table 156. Henan Tongyuan Pharmaceutical Description and Business Overview
Table 157. Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 159. Henan Tongyuan Pharmaceutical Recent Developments/Updates
Table 160. BAIHUI PHARMA Corporation Information
Table 161. BAIHUI PHARMA Description and Business Overview
Table 162. BAIHUI PHARMA Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. BAIHUI PHARMA Anti-Viral Cold And Flu Granule Product
Table 164. BAIHUI PHARMA Recent Developments/Updates
Table 165. Xiangxue Pharmaceutical Corporation Information
Table 166. Xiangxue Pharmaceutical Description and Business Overview
Table 167. Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 169. Xiangxue Pharmaceutical Recent Developments/Updates
Table 170. North Hulunbuir pharmaceutical limited company Corporation Information
Table 171. North Hulunbuir pharmaceutical limited company Description and Business Overview
Table 172. North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Product
Table 174. North Hulunbuir pharmaceutical limited company Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Anti-Viral Cold And Flu Granule Distributors List
Table 178. Anti-Viral Cold And Flu Granule Customers List
Table 179. Anti-Viral Cold And Flu Granule Market Trends
Table 180. Anti-Viral Cold And Flu Granule Market Drivers
Table 181. Anti-Viral Cold And Flu Granule Market Challenges
Table 182. Anti-Viral Cold And Flu Granule Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Viral Cold And Flu Granule
Figure 2. Global Anti-Viral Cold And Flu Granule Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Anti-Viral Cold And Flu Granule Market Share by Type in 2022 & 2034
Figure 4. Children's Edition Product Picture
Figure 5. Adults' Edition Product Picture
Figure 6. Global Anti-Viral Cold And Flu Granule Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Anti-Viral Cold And Flu Granule Market Share by Application in 2022 & 2034
Figure 8. Retail Pharmacies
Figure 9. Hospital
Figure 10. Online Sales Platforms
Figure 11. Global Anti-Viral Cold And Flu Granule Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Anti-Viral Cold And Flu Granule Market Size (2024-2034) & (US$ Million)
Figure 13. Global Anti-Viral Cold And Flu Granule Sales (2024-2034) & (K Units)
Figure 14. Global Anti-Viral Cold And Flu Granule Average Price (US$/Unit) & (2024-2034)
Figure 15. Anti-Viral Cold And Flu Granule Report Years Considered
Figure 16. Anti-Viral Cold And Flu Granule Sales Share by Manufacturers in 2022
Figure 17. Global Anti-Viral Cold And Flu Granule Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Anti-Viral Cold And Flu Granule Players: Market Share by Revenue in 2022
Figure 19. Anti-Viral Cold And Flu Granule Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 20. Global Anti-Viral Cold And Flu Granule Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 21. North America Anti-Viral Cold And Flu Granule Sales Market Share by Country (2024-2034)
Figure 22. North America Anti-Viral Cold And Flu Granule Revenue Market Share by Country (2024-2034)
Figure 23. United States Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Canada Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Europe Anti-Viral Cold And Flu Granule Sales Market Share by Country (2024-2034)
Figure 26. Europe Anti-Viral Cold And Flu Granule Revenue Market Share by Country (2024-2034)
Figure 27. Germany Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. France Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. U.K. Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Italy Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Russia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Asia Pacific Anti-Viral Cold And Flu Granule Sales Market Share by Region (2024-2034)
Figure 33. Asia Pacific Anti-Viral Cold And Flu Granule Revenue Market Share by Region (2024-2034)
Figure 34. China Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Japan Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. South Korea Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. India Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Australia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. China Taiwan Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Southeast Asia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Latin America Anti-Viral Cold And Flu Granule Sales Market Share by Country (2024-2034)
Figure 42. Latin America Anti-Viral Cold And Flu Granule Revenue Market Share by Country (2024-2034)
Figure 43. Mexico Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Brazil Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Argentina Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Colombia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Anti-Viral Cold And Flu Granule Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa Anti-Viral Cold And Flu Granule Revenue Market Share by Country (2024-2034)
Figure 49. Turkey Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE Anti-Viral Cold And Flu Granule Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Anti-Viral Cold And Flu Granule by Type (2024-2034)
Figure 53. Global Revenue Market Share of Anti-Viral Cold And Flu Granule by Type (2024-2034)
Figure 54. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Type (2024-2034)
Figure 55. Global Sales Market Share of Anti-Viral Cold And Flu Granule by Application (2024-2034)
Figure 56. Global Revenue Market Share of Anti-Viral Cold And Flu Granule by Application (2024-2034)
Figure 57. Global Anti-Viral Cold And Flu Granule Price (US$/Unit) by Application (2024-2034)
Figure 58. Anti-Viral Cold And Flu Granule Value Chain
Figure 59. Anti-Viral Cold And Flu Granule Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed